Bengaluru, India

Anisha Ambady

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Bactoclear Holdings Pte. Ltd. Active years: 2024-2025.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Anisha Ambady: Innovator in Therapeutic Bacteriocins

Introduction

Anisha Ambady is a prominent inventor based in Bengaluru, India. She has made significant contributions to the field of microbiology, particularly in the development of therapeutic bacteriocins. Her work focuses on innovative methods to combat microbial infections, showcasing her dedication to improving health outcomes.

Latest Patents

Anisha Ambady holds a patent for her invention titled "Therapeutic Bacteriocins." This invention provides methods and compositions aimed at reducing the growth of microbial colonies, including infections. It encompasses therapeutic compositions, methods for treating infections, and techniques for identifying additional such compositions. This patent highlights her innovative approach to addressing critical health challenges.

Career Highlights

Throughout her career, Anisha has worked with notable companies, including Bactoclear Holdings Pte. Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Anisha has collaborated with esteemed colleagues such as Chemira B Appaiah and Deepak Balasubramanian. These partnerships have further enriched her research and development efforts, leading to advancements in therapeutic solutions.

Conclusion

Anisha Ambady's work in therapeutic bacteriocins exemplifies her commitment to innovation in healthcare. Her contributions are paving the way for new treatments that can significantly impact the fight against microbial infections.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…